IncontiLase™

Incontilase

What is stress urinary incontinence?

Stress urinary incontinence (SUI) is a common problem in women that causes the involuntary loss of urine during coughing, sneezing, laughing, or physical exertion such as running or climbing stairs.

What are the causes of SUI?

The cause for this involuntary loss of urine is the weakening of the urethral closure mechanism, which is the result of changes in the pelvic floor region. The main contributing factors are vaginal child birth, obesity and aging.

What are the traditional treatment options?

Until now SUI was treated non-invasively through muscular training, known as Kegel exercises, which are only marginally effective since they rely on daily compliance. SUI is also treated invasively with a surgical implant known as a Urethral Sling. This procedure requires hospitalization, recovery time and could potentially cause serious complications.

How does IncontiLase™ work?

The laser has a photo thermal heating effect on collagen in both the vaginal walls and the urethra which causes restructuring and regrowth of the collagen. This results in thickening and tightening of the vaginal walls and urethra to improve atrophy and prevent urine loss.
This simple, non-surgical, 15 minute, in-office procedure is highly effective, pain free and safe. A special attachment, similar to a speculum as used during a pap test, is inserted into the vagina, during which the entire vaginal region is treated with short laser pulses through a small hand piece.*

*Results may vary from patient to patient and we will work with you to plan and refine your treatment plan.

Post Treatment

You can leave immediately after the procedure and continue your daily routine. There may be some minimal sensitivity after the procedure and a transparent discharge for 2-3 days afterwards. Sexual intercourse is not recommended for 1 week after the procedure.

 

The latest IncontiLase scientific results, presented by LAHA specialists Dr Riviera and Dr Fistonic, show excellent improvement for mild and moderate stress urinary incontinence. Assessements of efficacy were based on subjective patients’ evaluations through standardized questionnaires as well as objective Q-Tip and PFM measurements.

90% of patients with mild SUI and 76% of patients with moderate SUI needed just a single IncontiLase treatment. In total, 95% of all patients were incontinence -free 12 months after treatment, while 5% still had mild stress incontinence. Q-tip measurements during the Valsalva maneuver resulted in an average 20 degree decrease in Q-tip angle, objectively showing improvements in the urethra and bladder neck status*

*Results may vary from patient to patient and we will work with you to plan and refine your treatment plan.

TELL A FRIEND